Key opinion leaders (KOL) play a significant role in a biopharmaceutical product’s development by providing clinical and scientific expertise during initial phase, influencing peers and serving as advocates and spokespersons at product launch. However, increasing regulatory restrictions have forced biopharmaceutical companies to reassess their approach to KOL management.
This video provides guidelines for effective KOL development and engagement to promote long term viability. It discusses the strategic approaches to thought leader management to be adopted by an organization as it evolves, KOL management responsibility in the organization and interpreting the impact of legislative changes on business operations.
Insights from this video will help Medical Affairs professionals in comparing their approach to Key Opinion Leader management against industry standards and identify scope for improvement.